Quote | BioRestorative Therapies Inc (OTCMKTS:BRTXD)
Last: | $13.50 |
---|---|
Change Percent: | 3.81% |
Open: | $14.94 |
Close: | $13.50 |
High: | $14.94 |
Low: | $13.5 |
Volume: | 17,311 |
Last Trade Date Time: | 11/04/2021 04:54:31 pm |
News | BioRestorative Therapies Inc (OTCMKTS:BRTXD)
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today provided an update on its b...
— New therapeutic candidate developed using Company’s patented ThermoStem ® platform — — Candidate has potential to serve as an adjuvant to existing pharmaceuticals that are FDA approved and marketed towards weight loss — ...
Message Board Posts | BioRestorative Therapies Inc (OTCMKTS:BRTXD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
BioRestorative Therapies Inc Company Name:
BRTXD Stock Symbol:
OTCMKTS Market:
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today provided an update on its b...
— New therapeutic candidate developed using Company’s patented ThermoStem ® platform — — Candidate has potential to serve as an adjuvant to existing pharmaceuticals that are FDA approved and marketed towards weight loss — ...
- Company to provide update on exciting new commercial agreement, as well as Phase 2 clinical trial in Spine and preclinical development program in Obesity - MELVILLE, N.Y., April 30, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRT...